What was the main objective of the IM-UNITI maintenance study?
A. To investigate the efficacy and safety of Ustekinumab 90 mg q8w or q12w versus placebo over a 44-week period
B. To investigate the efficacy and safety of Ustekinumab 130 mg q5w or q10w versus placebo over a 44-week period
C. To investigate the efficacy and safety of Ustekinumab 80 mg q12w versus adalimumab or placebo over a 44-week period
D. To investigate the efficacy and safety of Ustekinumab ~6 mg/kg or 130 mg versus placebo over a 48-week period
Select your answer:
Topics:
Neurological Disorders Abnormal Psychology; Assessment and Diagnosis Histology of Nervous and Muscle Tissues Diseases Blood Formation and Clotting Deficiency Disease Leaves Macro and Micro Nutrients Carbohydrates Disease Prevention Child Growth and Development Renal, Cancer, HIV Human Anatomy Renal Thyroid and Intro to EndocrinologyOther quiz:
Hele Skeletal System › ViewWhat does an Orthopedic Surgeon do?
A. Is a nurse in the Operating Room
B. Operates on the heart
C. Operates on bones
D. Operates on the kidneys
Prokaryotic Cells and Viruses › View
Bacteria are eukaryotic cells. True or false?
A. TRUE
B. FALSE